JP2008007448A5 - - Google Patents

Download PDF

Info

Publication number
JP2008007448A5
JP2008007448A5 JP2006178118A JP2006178118A JP2008007448A5 JP 2008007448 A5 JP2008007448 A5 JP 2008007448A5 JP 2006178118 A JP2006178118 A JP 2006178118A JP 2006178118 A JP2006178118 A JP 2006178118A JP 2008007448 A5 JP2008007448 A5 JP 2008007448A5
Authority
JP
Japan
Prior art keywords
arg
ile
leu
pharmaceutical composition
lys
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006178118A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008007448A (ja
JP5076374B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2006178118A priority Critical patent/JP5076374B2/ja
Priority claimed from JP2006178118A external-priority patent/JP5076374B2/ja
Publication of JP2008007448A publication Critical patent/JP2008007448A/ja
Publication of JP2008007448A5 publication Critical patent/JP2008007448A5/ja
Application granted granted Critical
Publication of JP5076374B2 publication Critical patent/JP5076374B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2006178118A 2006-06-28 2006-06-28 医薬組成物 Expired - Fee Related JP5076374B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2006178118A JP5076374B2 (ja) 2006-06-28 2006-06-28 医薬組成物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2006178118A JP5076374B2 (ja) 2006-06-28 2006-06-28 医薬組成物

Publications (3)

Publication Number Publication Date
JP2008007448A JP2008007448A (ja) 2008-01-17
JP2008007448A5 true JP2008007448A5 (https=) 2009-07-16
JP5076374B2 JP5076374B2 (ja) 2012-11-21

Family

ID=39065968

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006178118A Expired - Fee Related JP5076374B2 (ja) 2006-06-28 2006-06-28 医薬組成物

Country Status (1)

Country Link
JP (1) JP5076374B2 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2253326B1 (en) 2008-02-28 2018-04-04 Toray Industries, Inc. Pharmaceutical composition for transnasal administration
CN104548069B (zh) * 2013-10-25 2017-02-08 四川大学 具有缓释性能的多肽‑降钙素超分子聚集体及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2521464C (en) * 2003-04-09 2013-02-05 Alnylam Pharmaceuticals, Inc. Irna conjugates
US20060014712A1 (en) * 2004-05-30 2006-01-19 Cemines, Inc. Controlled delivery of therapeutic compounds
EP1917274A2 (en) * 2005-07-28 2008-05-07 Oncotherapy Science, Inc. Vivit polypeptides, therapeutic agent comprising the same, and method of screening for anti-cancer agent

Similar Documents

Publication Publication Date Title
Batista et al. Recent insights in the use of nanocarriers for the oral delivery of bioactive proteins and peptides
Bakhru et al. Oral delivery of proteins by biodegradable nanoparticles
HRP20140616T1 (hr) Peptidni analog oksintomodulina
JP2023022318A (ja) ペプチドwkdeagkplvkを含む組成物
JP2013515057A5 (https=)
CN108478790B (zh) Bt脂肽作为用于肥胖和相关疾病的治疗剂的用途
JP2019533722A5 (https=)
CN1956735A (zh) 用于增强治疗剂黏膜吸收的递送剂
WO2018018010A1 (en) Fgf mutants and uses thereof
Youn et al. Improved peroral delivery of glucagon-like peptide-1 by site-specific biotin modification: design, preparation, and biological evaluation
JP2017519763A5 (https=)
WO2007061829A3 (en) Pharmaceutical composition
JP2009500045A5 (https=)
JP2018502854A (ja) 疾患および障害を処置するためのカルシトニン類似体
JP5212492B2 (ja) 経鼻投与用医薬組成物
JP2008007448A5 (https=)
Yao et al. The Disulfide Bond-Mediated Cyclization of Oral Peptides
Mankar et al. Basics and recent advances in peptide and protein drug delivery
TWI361694B (en) Use of bombesin/gastrin-releasing peptide antagonists for the treatment of sepsis or acute lung injury
RU2012109006A (ru) Инсулинсодержащий фармацевтический препарат для перорального применения
CN102307582A (zh) 作为蛋白酶抑制剂、用于保持肠中肽完整性的胆汁酸和双胍
Mehta et al. Technologies for Oral Delivery of Peptides
CN113061592B (zh) 修饰肽在制备抑制胰岛分泌胰岛素药物上的用途及修饰方法
Gough Starch based systems for the colonic delivery of bioactive peptides
HK40101653A (zh) 用於口服的活性剂的制剂